A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-10

AUTHORS

Edward Pan, Daohai Yu, Binglin Yue, Lisa Potthast, Sajeel Chowdhary, Pamela Smith, Marc Chamberlain

ABSTRACT

Single-agent sunitinib, an oral small molecule inhibitor of multiple tyrosine kinase receptors, was evaluated for treatment of patients with recurrent glioblastoma (GB) and anaplastic astrocytoma (AA). Fourteen AA and 16 GB patients, all previously treated with surgery, radiotherapy, and temozolomide, were enrolled in a prospective phase II study at either first or second relapse. Patients were treated with daily sunitinib for 4 consecutive weeks, followed by a 2-week break. For AA patients, the most common side effects were fatigue (86 %), diarrhea (43 %), hand-foot syndrome (36 %), neutropenia (36 %), thrombocytopenia (36 %), and nausea (29 %). In the GB cohort, the most common side effects were fatigue (56 %), diarrhea (44 %), neutropenia (31 %), and thrombocytopenia (25 %). Six of 14 (43 %) AA and 5 of 16 (31 %) GB patients experienced grade 3 or greater toxicities. Five patients discontinued study due to drug toxicities. There were no partial or complete responses in either cohort; 8/14 (57 %) AA and 5/16 (31 %) GB patients had stable disease at the first planned assessment. Progression-free survival at 6 months was 21.5 % (AA) and 16.7 % (GB). Median overall survival was 12.1 months (AA) and 12.6 months (GB). These results are comparable to those reported in the literature in patients treated with standard cytotoxic therapies. This is the largest reported trial of sunitinib in recurrent malignant astrocytic gliomas to date, as well as contains the largest AA cohort. Nonetheless, sunitinib did not demonstrate significant anti-glioma activity in patients with recurrent malignant astrocytic gliomas. More... »

PAGES

111-118

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11060-012-0943-z

DOI

http://dx.doi.org/10.1007/s11060-012-0943-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1011277852

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22832897


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Indoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Recurrence, Local", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrroles", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Moffitt Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.468198.a", 
          "name": [
            "Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr., 33612-9416, Tampa, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pan", 
        "givenName": "Edward", 
        "id": "sg:person.0741244140.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741244140.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Moffitt Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.468198.a", 
          "name": [
            "Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr., 33612-9416, Tampa, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yu", 
        "givenName": "Daohai", 
        "id": "sg:person.01276732406.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276732406.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Moffitt Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.468198.a", 
          "name": [
            "Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr., 33612-9416, Tampa, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yue", 
        "givenName": "Binglin", 
        "id": "sg:person.01202762674.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202762674.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Moffitt Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.468198.a", 
          "name": [
            "Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr., 33612-9416, Tampa, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Potthast", 
        "givenName": "Lisa", 
        "id": "sg:person.01043757137.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043757137.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Florida Hospital Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.414938.3", 
          "name": [
            "Department of Neuro-Oncology, Florida Hospital Cancer Institute, Orlando, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chowdhary", 
        "givenName": "Sajeel", 
        "id": "sg:person.0614025645.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614025645.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Moffitt Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.468198.a", 
          "name": [
            "Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr., 33612-9416, Tampa, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smith", 
        "givenName": "Pamela", 
        "id": "sg:person.0606626241.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606626241.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Seattle Cancer Care Alliance", 
          "id": "https://www.grid.ac/institutes/grid.430269.a", 
          "name": [
            "Department of Neurology and Neurological Surgery, Seattle Cancer Care Alliance, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chamberlain", 
        "givenName": "Marc", 
        "id": "sg:person.01326261166.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-06-2309", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004441322"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.16.3055", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010751135"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/noq017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011865671"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.26138", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014116328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1096/fj.01-0700com", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014928365"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.23.6497", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024766199"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-008-9722-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029000688", 
          "https://doi.org/10.1007/s11060-008-9722-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.23.2595", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037090164"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2990.2003.00535.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042209963"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.26.3541", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043187529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1541-7786.mcr-06-0085", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043369568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-006-9225-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049763858", 
          "https://doi.org/10.1007/s11060-006-9225-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-011-0631-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050240889", 
          "https://doi.org/10.1007/s11060-011-0631-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-010-0402-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050941168", 
          "https://doi.org/10.1007/s11060-010-0402-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa043330", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052112015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-06-2328", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053214374"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0197-2456(89)90015-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053744925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0197-2456(89)90015-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053744925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064350042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064350042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064350042"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1215/15228517-2007-024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064414289"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1215/15228517-2008-088", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064414384"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.8.2572", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074549881"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075266207", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075562439", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077595157", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2011.0037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078376978"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2011.0037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078376978"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1990.8.7.1277", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078716995"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-10", 
    "datePublishedReg": "2012-10-01", 
    "description": "Single-agent sunitinib, an oral small molecule inhibitor of multiple tyrosine kinase receptors, was evaluated for treatment of patients with recurrent glioblastoma (GB) and anaplastic astrocytoma (AA). Fourteen AA and 16 GB patients, all previously treated with surgery, radiotherapy, and temozolomide, were enrolled in a prospective phase II study at either first or second relapse. Patients were treated with daily sunitinib for 4 consecutive weeks, followed by a 2-week break. For AA patients, the most common side effects were fatigue (86 %), diarrhea (43 %), hand-foot syndrome (36 %), neutropenia (36 %), thrombocytopenia (36 %), and nausea (29 %). In the GB cohort, the most common side effects were fatigue (56 %), diarrhea (44 %), neutropenia (31 %), and thrombocytopenia (25 %). Six of 14 (43 %) AA and 5 of 16 (31 %) GB patients experienced grade 3 or greater toxicities. Five patients discontinued study due to drug toxicities. There were no partial or complete responses in either cohort; 8/14 (57 %) AA and 5/16 (31 %) GB patients had stable disease at the first planned assessment. Progression-free survival at 6 months was 21.5 % (AA) and 16.7 % (GB). Median overall survival was 12.1 months (AA) and 12.6 months (GB). These results are comparable to those reported in the literature in patients treated with standard cytotoxic therapies. This is the largest reported trial of sunitinib in recurrent malignant astrocytic gliomas to date, as well as contains the largest AA cohort. Nonetheless, sunitinib did not demonstrate significant anti-glioma activity in patients with recurrent malignant astrocytic gliomas.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s11060-012-0943-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2438867", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1094205", 
        "issn": [
          "0167-594X", 
          "1573-7373"
        ], 
        "name": "Journal of Neuro-Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "110"
      }
    ], 
    "name": "A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma", 
    "pagination": "111-118", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "35bb9bebdace67ab7bef2d09248d465f80821b2169aacced5cb851af8e7c0175"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22832897"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309335"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11060-012-0943-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1011277852"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11060-012-0943-z", 
      "https://app.dimensions.ai/details/publication/pub.1011277852"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000530.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs11060-012-0943-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11060-012-0943-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11060-012-0943-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11060-012-0943-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11060-012-0943-z'


 

This table displays all metadata directly associated to this object as RDF triples.

254 TRIPLES      21 PREDICATES      69 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11060-012-0943-z schema:about N063672c0445a4ab4a79db4b23fb3d83f
2 N182d0901e9d749ef85b48067f7e42ac7
3 N1d00abc482dd4022a044724d05609f52
4 N59b165c1105540b985e6c2f02153f1e8
5 N798010ca572e46bcbd11c1c81066b5a7
6 N798a19901448463787afdcf25f92ee7b
7 Na0c4fdea59c144b28ca4d11644d71f83
8 Na300da361c95461696b6f4d993229cdd
9 Nb6340ae3cead4bd6a6478fa7890224bf
10 Nc3e371c4ca7c45249cdc479a9d48ac03
11 Nca2589e5a67148f6bf9daa7e4b67da41
12 Nd08c4b6aa5b6428e935a56834c57892e
13 Ne09d6070754444239efe929fdbbb4662
14 Nfddf6c593b5046adb01c2bc8ce295389
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author Nd6b4265f73a6440b9b10583a03240332
18 schema:citation sg:pub.10.1007/s11060-006-9225-y
19 sg:pub.10.1007/s11060-008-9722-2
20 sg:pub.10.1007/s11060-010-0402-7
21 sg:pub.10.1007/s11060-011-0631-4
22 https://app.dimensions.ai/details/publication/pub.1075266207
23 https://app.dimensions.ai/details/publication/pub.1075562439
24 https://app.dimensions.ai/details/publication/pub.1077595157
25 https://doi.org/10.1002/cncr.26138
26 https://doi.org/10.1016/0197-2456(89)90015-9
27 https://doi.org/10.1056/nejmoa043330
28 https://doi.org/10.1093/neuonc/noq017
29 https://doi.org/10.1096/fj.01-0700com
30 https://doi.org/10.1111/j.1365-2990.2003.00535.x
31 https://doi.org/10.1158/1078-0432.ccr-06-2309
32 https://doi.org/10.1158/1078-0432.ccr-06-2328
33 https://doi.org/10.1158/1541-7786.mcr-06-0085
34 https://doi.org/10.1200/jco.1990.8.7.1277
35 https://doi.org/10.1200/jco.1999.17.8.2572
36 https://doi.org/10.1200/jco.2008.16.3055
37 https://doi.org/10.1200/jco.2009.23.2595
38 https://doi.org/10.1200/jco.2009.23.6497
39 https://doi.org/10.1200/jco.2009.26.3541
40 https://doi.org/10.1212/01.wnl.0000304121.57857.38
41 https://doi.org/10.1215/15228517-2007-024
42 https://doi.org/10.1215/15228517-2008-088
43 https://doi.org/10.6004/jnccn.2011.0037
44 schema:datePublished 2012-10
45 schema:datePublishedReg 2012-10-01
46 schema:description Single-agent sunitinib, an oral small molecule inhibitor of multiple tyrosine kinase receptors, was evaluated for treatment of patients with recurrent glioblastoma (GB) and anaplastic astrocytoma (AA). Fourteen AA and 16 GB patients, all previously treated with surgery, radiotherapy, and temozolomide, were enrolled in a prospective phase II study at either first or second relapse. Patients were treated with daily sunitinib for 4 consecutive weeks, followed by a 2-week break. For AA patients, the most common side effects were fatigue (86 %), diarrhea (43 %), hand-foot syndrome (36 %), neutropenia (36 %), thrombocytopenia (36 %), and nausea (29 %). In the GB cohort, the most common side effects were fatigue (56 %), diarrhea (44 %), neutropenia (31 %), and thrombocytopenia (25 %). Six of 14 (43 %) AA and 5 of 16 (31 %) GB patients experienced grade 3 or greater toxicities. Five patients discontinued study due to drug toxicities. There were no partial or complete responses in either cohort; 8/14 (57 %) AA and 5/16 (31 %) GB patients had stable disease at the first planned assessment. Progression-free survival at 6 months was 21.5 % (AA) and 16.7 % (GB). Median overall survival was 12.1 months (AA) and 12.6 months (GB). These results are comparable to those reported in the literature in patients treated with standard cytotoxic therapies. This is the largest reported trial of sunitinib in recurrent malignant astrocytic gliomas to date, as well as contains the largest AA cohort. Nonetheless, sunitinib did not demonstrate significant anti-glioma activity in patients with recurrent malignant astrocytic gliomas.
47 schema:genre research_article
48 schema:inLanguage en
49 schema:isAccessibleForFree true
50 schema:isPartOf N2a41038a7fc44bd9b073abdb3500112b
51 N9709ebd0d1c848e09db9ccbf9c831ada
52 sg:journal.1094205
53 schema:name A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma
54 schema:pagination 111-118
55 schema:productId N2232b824cb894fcdb8e10754be9862b7
56 N284f9989a21947ab91293a69531e08ab
57 N6c323c41d041469d8924ff31c6faa864
58 N77b8510ae8e24ae0b416ad5a7e1be066
59 Ndc32beb120b84543901cb9b90f70a8c0
60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011277852
61 https://doi.org/10.1007/s11060-012-0943-z
62 schema:sdDatePublished 2019-04-10T15:05
63 schema:sdLicense https://scigraph.springernature.com/explorer/license/
64 schema:sdPublisher Ne1f1b87830364d56a39d4d77f33a2bcf
65 schema:url http://link.springer.com/10.1007%2Fs11060-012-0943-z
66 sgo:license sg:explorer/license/
67 sgo:sdDataset articles
68 rdf:type schema:ScholarlyArticle
69 N041ce6255654408495c68adaa69212a6 rdf:first sg:person.01326261166.36
70 rdf:rest rdf:nil
71 N063672c0445a4ab4a79db4b23fb3d83f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Middle Aged
73 rdf:type schema:DefinedTerm
74 N182d0901e9d749ef85b48067f7e42ac7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Antineoplastic Agents
76 rdf:type schema:DefinedTerm
77 N1d00abc482dd4022a044724d05609f52 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Male
79 rdf:type schema:DefinedTerm
80 N2232b824cb894fcdb8e10754be9862b7 schema:name nlm_unique_id
81 schema:value 8309335
82 rdf:type schema:PropertyValue
83 N284f9989a21947ab91293a69531e08ab schema:name pubmed_id
84 schema:value 22832897
85 rdf:type schema:PropertyValue
86 N2a41038a7fc44bd9b073abdb3500112b schema:volumeNumber 110
87 rdf:type schema:PublicationVolume
88 N5245f97d7c7b4696a5f8433f884b0f55 rdf:first sg:person.01276732406.03
89 rdf:rest N7a67e47e5998489581c7d121502ceb95
90 N5327151d47954365a3999eb279050837 rdf:first sg:person.0614025645.14
91 rdf:rest N85bdedab3f8547b8be9b50d4ea87896f
92 N59b165c1105540b985e6c2f02153f1e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Indoles
94 rdf:type schema:DefinedTerm
95 N6c323c41d041469d8924ff31c6faa864 schema:name doi
96 schema:value 10.1007/s11060-012-0943-z
97 rdf:type schema:PropertyValue
98 N77b8510ae8e24ae0b416ad5a7e1be066 schema:name dimensions_id
99 schema:value pub.1011277852
100 rdf:type schema:PropertyValue
101 N798010ca572e46bcbd11c1c81066b5a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Brain Neoplasms
103 rdf:type schema:DefinedTerm
104 N798a19901448463787afdcf25f92ee7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Humans
106 rdf:type schema:DefinedTerm
107 N7a67e47e5998489581c7d121502ceb95 rdf:first sg:person.01202762674.87
108 rdf:rest N8384c46f763f4cfdb58f55765fefa7bb
109 N8384c46f763f4cfdb58f55765fefa7bb rdf:first sg:person.01043757137.67
110 rdf:rest N5327151d47954365a3999eb279050837
111 N85bdedab3f8547b8be9b50d4ea87896f rdf:first sg:person.0606626241.20
112 rdf:rest N041ce6255654408495c68adaa69212a6
113 N9709ebd0d1c848e09db9ccbf9c831ada schema:issueNumber 1
114 rdf:type schema:PublicationIssue
115 Na0c4fdea59c144b28ca4d11644d71f83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Disease-Free Survival
117 rdf:type schema:DefinedTerm
118 Na300da361c95461696b6f4d993229cdd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Neoplasm Recurrence, Local
120 rdf:type schema:DefinedTerm
121 Nb6340ae3cead4bd6a6478fa7890224bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Female
123 rdf:type schema:DefinedTerm
124 Nc3e371c4ca7c45249cdc479a9d48ac03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Kaplan-Meier Estimate
126 rdf:type schema:DefinedTerm
127 Nca2589e5a67148f6bf9daa7e4b67da41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Adult
129 rdf:type schema:DefinedTerm
130 Nd08c4b6aa5b6428e935a56834c57892e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Glioma
132 rdf:type schema:DefinedTerm
133 Nd6b4265f73a6440b9b10583a03240332 rdf:first sg:person.0741244140.25
134 rdf:rest N5245f97d7c7b4696a5f8433f884b0f55
135 Ndc32beb120b84543901cb9b90f70a8c0 schema:name readcube_id
136 schema:value 35bb9bebdace67ab7bef2d09248d465f80821b2169aacced5cb851af8e7c0175
137 rdf:type schema:PropertyValue
138 Ne09d6070754444239efe929fdbbb4662 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Pyrroles
140 rdf:type schema:DefinedTerm
141 Ne1f1b87830364d56a39d4d77f33a2bcf schema:name Springer Nature - SN SciGraph project
142 rdf:type schema:Organization
143 Nfddf6c593b5046adb01c2bc8ce295389 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Aged
145 rdf:type schema:DefinedTerm
146 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
147 schema:name Medical and Health Sciences
148 rdf:type schema:DefinedTerm
149 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
150 schema:name Oncology and Carcinogenesis
151 rdf:type schema:DefinedTerm
152 sg:grant.2438867 http://pending.schema.org/fundedItem sg:pub.10.1007/s11060-012-0943-z
153 rdf:type schema:MonetaryGrant
154 sg:journal.1094205 schema:issn 0167-594X
155 1573-7373
156 schema:name Journal of Neuro-Oncology
157 rdf:type schema:Periodical
158 sg:person.01043757137.67 schema:affiliation https://www.grid.ac/institutes/grid.468198.a
159 schema:familyName Potthast
160 schema:givenName Lisa
161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01043757137.67
162 rdf:type schema:Person
163 sg:person.01202762674.87 schema:affiliation https://www.grid.ac/institutes/grid.468198.a
164 schema:familyName Yue
165 schema:givenName Binglin
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202762674.87
167 rdf:type schema:Person
168 sg:person.01276732406.03 schema:affiliation https://www.grid.ac/institutes/grid.468198.a
169 schema:familyName Yu
170 schema:givenName Daohai
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276732406.03
172 rdf:type schema:Person
173 sg:person.01326261166.36 schema:affiliation https://www.grid.ac/institutes/grid.430269.a
174 schema:familyName Chamberlain
175 schema:givenName Marc
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326261166.36
177 rdf:type schema:Person
178 sg:person.0606626241.20 schema:affiliation https://www.grid.ac/institutes/grid.468198.a
179 schema:familyName Smith
180 schema:givenName Pamela
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606626241.20
182 rdf:type schema:Person
183 sg:person.0614025645.14 schema:affiliation https://www.grid.ac/institutes/grid.414938.3
184 schema:familyName Chowdhary
185 schema:givenName Sajeel
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614025645.14
187 rdf:type schema:Person
188 sg:person.0741244140.25 schema:affiliation https://www.grid.ac/institutes/grid.468198.a
189 schema:familyName Pan
190 schema:givenName Edward
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0741244140.25
192 rdf:type schema:Person
193 sg:pub.10.1007/s11060-006-9225-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1049763858
194 https://doi.org/10.1007/s11060-006-9225-y
195 rdf:type schema:CreativeWork
196 sg:pub.10.1007/s11060-008-9722-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029000688
197 https://doi.org/10.1007/s11060-008-9722-2
198 rdf:type schema:CreativeWork
199 sg:pub.10.1007/s11060-010-0402-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050941168
200 https://doi.org/10.1007/s11060-010-0402-7
201 rdf:type schema:CreativeWork
202 sg:pub.10.1007/s11060-011-0631-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050240889
203 https://doi.org/10.1007/s11060-011-0631-4
204 rdf:type schema:CreativeWork
205 https://app.dimensions.ai/details/publication/pub.1075266207 schema:CreativeWork
206 https://app.dimensions.ai/details/publication/pub.1075562439 schema:CreativeWork
207 https://app.dimensions.ai/details/publication/pub.1077595157 schema:CreativeWork
208 https://doi.org/10.1002/cncr.26138 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014116328
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1016/0197-2456(89)90015-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053744925
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1056/nejmoa043330 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052112015
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1093/neuonc/noq017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011865671
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1096/fj.01-0700com schema:sameAs https://app.dimensions.ai/details/publication/pub.1014928365
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1111/j.1365-2990.2003.00535.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1042209963
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1158/1078-0432.ccr-06-2309 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004441322
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1158/1078-0432.ccr-06-2328 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053214374
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1158/1541-7786.mcr-06-0085 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043369568
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1200/jco.1990.8.7.1277 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078716995
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1200/jco.1999.17.8.2572 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074549881
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1200/jco.2008.16.3055 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010751135
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1200/jco.2009.23.2595 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037090164
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1200/jco.2009.23.6497 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024766199
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1200/jco.2009.26.3541 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043187529
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1212/01.wnl.0000304121.57857.38 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064350042
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1215/15228517-2007-024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064414289
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1215/15228517-2008-088 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064414384
243 rdf:type schema:CreativeWork
244 https://doi.org/10.6004/jnccn.2011.0037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078376978
245 rdf:type schema:CreativeWork
246 https://www.grid.ac/institutes/grid.414938.3 schema:alternateName Florida Hospital Cancer Institute
247 schema:name Department of Neuro-Oncology, Florida Hospital Cancer Institute, Orlando, FL, USA
248 rdf:type schema:Organization
249 https://www.grid.ac/institutes/grid.430269.a schema:alternateName Seattle Cancer Care Alliance
250 schema:name Department of Neurology and Neurological Surgery, Seattle Cancer Care Alliance, Seattle, WA, USA
251 rdf:type schema:Organization
252 https://www.grid.ac/institutes/grid.468198.a schema:alternateName Moffitt Cancer Center
253 schema:name Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr., 33612-9416, Tampa, FL, USA
254 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...